Antonios Douros

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 48

Top Venues

Diabetes care

Diabetes, obesity & metabolism

British journal of clinical pharmacology

Drug safety

Lady Davis Institute for Medical Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Lady Davis Institute for Medical Research Jan 01 2019

Canada

Investigator :: Clinical Epidemiology

McGill University Jan 01 2019

Canada

Assistant Professor :: Medicine

McGill University Oct 01 2016 - Dec 31 2018

Canada

Postdoctoral Research Fellow :: Epidemiology

Charité Universitätsmedizin Berlin Jan 01 2012 - Sep 30 2016

Germany

Resident :: Clinical Pharmacology and Toxicology

Leibniz-Institut für Präventionsforschung und Epidemiologie - BIPS GmbH Sep 01 2014 - Sep 30 2015

Germany

Research Fellow :: Clinical Epidemiology

Publications

Christopher A Gravel, William Bai, Antonios Douros
Comparators in Pharmacovigilance: A Quasi-Quantification Bias Analysis. Drug safety 47 (8) (2024)
Tim Bothe, Anne-Katrin Fietz, Elke Schäffner, Antonios Douros, Anna Pöhlmann, Nina Mielke, Cédric Villain, Muhammad Helmi Barghouth, Volker Wenning, Natalie Ebert
Diagnostic Validity of Chronic Kidney Disease in Health Claims Data Over Time: Results from a Cohort of Community-Dwelling Older Adults in Germany. Clinical epidemiology 16 (2024)
Christopher A Gravel, William Bai, Antonios Douros
Comparators in Pharmacovigilance: A Quasi-Quantification Bias Analysis. Drug safety (2024)
Christopher A Gravel, William Bai, Antonios Douros
Comparators in Pharmacovigilance: A Quasi-Quantification Bias Analysis. Drug safety 47 (8) (2024)
Shahrzad Salmasi, Samuel Igweokpala, Antonios Douros, Nehal Islam, Jason G Andrade, Kristian B Filion
Opioid Use and the Risk of Ventricular Arrhythmias: A Systematic Review and Meta-Analysis. Pharmacoepidemiology and drug safety 33 (8) (2024)
Shahrzad Salmasi, Samuel Igweokpala, Antonios Douros, Nehal Islam, Jason G Andrade, Kristian B Filion
Opioid Use and the Risk of Ventricular Arrhythmias: A Systematic Review and Meta-Analysis. Pharmacoepidemiology and drug safety 33 (8) (2024)
Christopher A Gravel, William Bai, Antonios Douros
Comparators in Pharmacovigilance: A Quasi-Quantification Bias Analysis. Drug safety 47 (8) (2024)
Tim Bothe, Anne-Katrin Fietz, Elke Schäffner, Antonios Douros, Anna Pöhlmann, Nina Mielke, Cédric Villain, Muhammad Helmi Barghouth, Volker Wenning, Natalie Ebert
Diagnostic Validity of Chronic Kidney Disease in Health Claims Data Over Time: Results from a Cohort of Community-Dwelling Older Adults in Germany. Clinical epidemiology 16 (2024)
Jenny Dimakos, Ying Cui, Robert W Platt, Christel Renoux, Kristian B Filion, Antonios Douros
Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study. Diabetes, obesity & metabolism 26 (8) (2024)
Jenny Dimakos, Ying Cui, Robert W Platt, Christel Renoux, Kristian B Filion, Antonios Douros
Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study. Diabetes, obesity & metabolism (2024)
Jenny Dimakos, Ying Cui, Robert W Platt, Christel Renoux, Kristian B Filion, Antonios Douros
Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes care 46 (2) (2023)
Christopher A Gravel, Daniel Krewski, Donald R Mattison, Franco Momoli, Antonios Douros
Concomitant use of statins and sodium-glucose co-transporter 2 inhibitors and the risk of myotoxicity reporting - A disproportionality analysis. British journal of clinical pharmacology (2023)
Nehal Islam, Pauline Reynier, Antonios Douros, Oriana H Y Yu, Kristian B Filion
Sulphonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: A population-based cohort study. Diabetes, obesity & metabolism (2023)
Nehal Islam, Pauline Reynier, Antonios Douros, Oriana H Y Yu, Kristian B Filion
Sulfonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: a population-based cohort study. Diabetes, obesity & metabolism (2023)
Jenny Dimakos, Ying Cui, Robert W Platt, Christel Renoux, Kristian B Filion, Antonios Douros
Pharmacologic heterogeneity and risk of severe hypoglycemia with concomitant use of sulfonylureas and DPP-4 inhibitors: population-based cohort study. Clinical pharmacology and therapeutics (2023)
Christopher A Gravel, Antonios Douros
Considerations on the use of different comparators in pharmacovigilance: a methodological review. British journal of clinical pharmacology (2023)
Jenny Dimakos, Ying Cui, Robert W Platt, Christel Renoux, Kristian B Filion, Antonios Douros
Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes care 46 (2) (2023)
Samuel Igweokpala, Naheemot Olaoluwa Sule, Antonios Douros, Oriana H Y Yu, Kristian B Filion
Incretin-based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta-analysis of observational studies. Diabetes, obesity & metabolism (2023)
Cédric Villain, Natalie Ebert, Tim Bothe, Muhammad Helmi Barghouth, Anna Pöhlmann, Anne-Katrin Fietz, Antonios Douros, Nina Mielke, Elke Schäffner
Kidney function estimators for drug dose adjustment of direct oral anticoagulants in older adults with atrial fibrillation. Clinical kidney journal 16 (12) (2023)
Jenny Dimakos, Ying Cui, Robert W Platt, Christel Renoux, Kristian B Filion, Antonios Douros
Concomitant Use of Sulfonylureas and Warfarin and the Risk of Severe Hypoglycemia: Population-Based Cohort Study. Diabetes care 45 (10) (2022)
Jenny Dimakos, Ying Cui, Robert W Platt, Christel Renoux, Kristian B Filion, Antonios Douros
Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes care (2022)
Antonios Douros, Frederike Basedow, Ying Cui, Jochen Walker, Dirk Enders, Vicky Tagalakis
Effectiveness and safety of direct oral anticoagulants with antiplatelet agents in patients with venous thromboembolism: A multi-database cohort study. Research and practice in thrombosis and haemostasis 6 (1) (2022)
Nehal Islam, Henok Tadesse Ayele, Oriana H Y Yu, Antonios Douros, Kristian B Filion
Response to: Real-World Data on the Risk of Ventricular Arrhythmias with Sulfonamides. Clinical pharmacology and therapeutics 112 (2) (2022)
Antonios Douros, Zharmaine Ante, Samy Suissa, Paul Brassard
Common vaccines and the risk of incident dementia: a population-based cohort study. The Journal of infectious diseases (2022)
Jihoon Lim, Imen Farhat, Antonios Douros, Dimitra Panagiotoglou
Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials. PloS one 17 (3) (2022)
Camille Simard, Lindsey Gerstein, Teresa Cafaro, Kris B Filion, Antonios Douros, Isabelle Malhamé, Vicky Tagalakis, null null
Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature. Research and practice in thrombosis and haemostasis 6 (6) (2022)
Henok Tadesse Ayele, Antonios Douros, Kristian B Filion
5-α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population-based cohort study. British journal of clinical pharmacology 88 (8) (2022)
Linda B Ou, Carolina Moriello, Antonios Douros, Kristian B Filion
Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies. British journal of clinical pharmacology 87 (10) (2021)
Antonios Douros, Ying Cui, Robert W Platt, Kristian B Filion, Giada Sebastiani, Christel Renoux
Utilization and long-term persistence of direct oral anticoagulants among patients with nonvalvular atrial fibrillation and liver disease. British journal of clinical pharmacology (2021)
Seoyoung C Kim, Sebastian Schneeweiss, Antonios Douros, Kristian B Filion, Hui Yin, Elisabetta Patorno, Laurent Azoulay
The modifying effects of adiposity on the cardiovascular safety of sulphonylureas. Diabetes, obesity & metabolism 23 (11) (2021)
Michael Dörks, Kathrin Jobski, Stefan Herget-Rosenthal, Falk Hoffmann, Antonios Douros
Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection-A pharmacovigilance analysis. Pharmacology research & perspectives 9 (1) (2021)
Tianze Jiao, Robert W Platt, Antonios Douros, Kristian B Filion
Prescription Patterns for the Use of Antihypertensive Drugs for Primary Prevention among Patients with Hypertension in the United Kingdom. American journal of hypertension (2021)
Michael Dörks, Kathrin Jobski, Falk Hoffmann, Antonios Douros
Global COVID-19 pandemic and reporting behavior - An analysis of the Food and Drug Administration adverse events reporting system. Pharmacoepidemiology and drug safety 30 (6) (2021)
Panagiotis Nikolaos Lalagkas, Georgios Poulentzas, Christos A Kontogiorgis, Antonios Douros
Potential drug-drug interaction between sodium-glucose co-transporter 2 inhibitors and statins: pharmacological and clinical evidence. Expert opinion on drug metabolism & toxicology 17 (6) (2021)
Oriana Hoi Yun Yu, Sophie Dell'Aniello, Baiju R Shah, Vanessa C Brunetti, Jean-Marc Daigle, Michael Fralick, Antonios Douros, Nianping Hu, Silvia Alessi-Severini, Anat Fisher, Shawn C Bugden, Paul E Ronksley, Kristian B Filion, Pierre Ernst, Lisa M Lix, null null
Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Below-Knee Amputation: A Multicenter Observational Study. Diabetes care 43 (10) (2020)
Antonios Douros, Lisa M Lix, Michael Fralick, Sophie Dell'Aniello, Baiju R Shah, Paul E Ronksley, Éric Tremblay, Nianping Hu, Silvia Alessi-Severini, Anat Fisher, Shawn C Bugden, Pierre Ernst, Kristian B Filion, null null
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study. Annals of internal medicine 173 (6) (2020)
Antonios Douros, Jean-Francois Boivin, Christel Renoux
Author response: Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study. Neurology 95 (5) (2020)
Donald Mattison, Christopher Gravel, Daniel Krewski, Laurent Azoulay, Blánaid Hicks, Antonios Douros
Direct oral anticoagulants and oesophageal disorders: a pharmacovigilance analysis. European journal of clinical pharmacology 76 (7) (2020)
Anat Fisher, Michael Fralick, Kristian B Filion, Sophie Dell'Aniello, Antonios Douros, Éric Tremblay, Baiju R Shah, Paul E Ronksley, Silvia Alessi-Severini, Nianping Hu, Shawn C Bugden, Pierre Ernst, Lisa M Lix, null null
Sodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort study. Diabetes, obesity & metabolism 22 (9) (2020)
Farzin Khosrow-Khavar, Siyana Kurteva, Ying Cui, Kristian B Filion, Antonios Douros
Opioids and the Risk of Infection: A Critical Appraisal of the Pharmacologic and Clinical Evidence. Expert opinion on drug metabolism & toxicology 15 (7) (2019)
Antonios Douros, Julie Rouette, Hui Yin, Oriana Hoi Yun Yu, Kristian B Filion, Laurent Azoulay
Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes. Diabetes care 42 (8) (2019)
Antonios Douros, Sophie Dell'Aniello, Oriana Hoi Yun Yu, Samy Suissa
Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population-based cohort study. Diabetes, obesity & metabolism 22 (2) (2019)
Antonios Douros, Sophie Dell'Aniello, Golsa Dehghan, Jean-François Boivin, Christel Renoux
Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study. Neurology 93 (10) (2019)
Kristian B Filion, Antonios Douros, Laurent Azoulay, Hui Yin, Oriana H Yu, Samy Suissa
Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study. British journal of clinical pharmacology 85 (10) (2019)
Devin Abrahami, Antonios Douros, Hui Yin, Oriana H Y Yu, Laurent Azoulay
Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes. Diabetes care 42 (9) (2019)
Antonios Douros, Matthew Ades, Christel Renoux
Risk of Intracranial Hemorrhage Associated with the Use of Antidepressants Inhibiting Serotonin Reuptake: A Systematic Review. CNS drugs 32 (4) (2019)
Antonios Douros, Kristian B Filion, Hui Yin, Oriana Hoi Yu, Mahyar Etminan, Jacob A Udell, Laurent Azoulay
Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy. Diabetes care 41 (11) (2018)
Antonios Douros, Christel Renoux, Janie Coulombe, Samy Suissa
Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study. Pharmacoepidemiology and drug safety 26 (12) (2017)

Antonios Douros.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Antonios Douros